National Intellectual Property Section

1. Selection Patent Requires Reliable Scientific Data
   Pfizer Canada Inc. and Warner-Lambert Co. v. Apotex and Minister of Health 2008 FC 13 (Barnes J.)

2. Prior Federal Court of Appeal Ruling on Patent’s Validity Dispositive
   Pfizer Canada Inc. and Parke, Davis & Co. v. Novopharm and Minister of Health 2008 FC 11 (Hughes J.)

3. Injunction loses on irreparable harm
   CMAC mortgages ltd., CMAC Mortgages (Alberta) Ltd., and Ontario Mortgage Action Centre Ltd., c.o.b. OMAC v. Canadian Mortgage Expert Centres Ltd. 2008 FC 6 (Lemieux, J.)

4. There is No Discretion to Refuse Patent Disclaimers
   Distrimedic Inc. v. Richards Packing Inc., 2008 FCA 4 (Décary, Létourneau, Nadon, JJ.A.)

5. Federal Court of Appeal Upholds Ringtone Royalties
   Canadian Wireless Telecommunications Association v. Society of Composers, Authors and Music Publishers of Canada (2008 FCA 6) A-391-06 (Sexton, Sharlow, & Ryer JJ.A.)

6. Delay in application noted in failed injunction appeal
   Hyundai Auto Canada v. Cross Canada Auto Body Supply Ltd. 2008 FCA 12 (Exton, J.A.)

7. Patent owner can be added at any time to NOC proceedings
   Cobalt Pharmaceuticals Inc. et al. v. Pfizer Canada Inc. et al. 2008 FCA 15 (Desjardins J.A.)

8. Music Memory is Tariff Free
   Apple Canada Inc. v. Canadian Private Copying Collective (2008 FCA 9) A-369-07 and A-370-07 (Richard C.J, Sharlow, & Ryer JJ.A.)

9. Motion to Set Aside Default Judgment Dismissed
   Louis Vuitton Malletier S.A. and Louis Vuitton Canada, Inc. (“LV”) v. Lin Pi-Chu Yang et al 2008 FC 45 (Snider J.)

10. Rules interpreted and pleadings upheld
    Simpson Strong-Tie Company, Inc. v. Peak Innovations Inc. 2008 FC 52 (Lafrenière, P.)

11. Bioequivalence may not necessarily include the establishment of a safe limit of a certain impurity in an ANDS
    Bayer Healthcare AG et al. v. Sandoz Canada Incorporated et al. 2008 FCA 25 (Trudel J.A.)

12. L’annulation d’une ordonnance rendue sur requête ex parte par al. 399 (1)(a) des Règles des Cours fédérales: le choix de la langue officielle est celui de la demanderesse (al. 68(1))
    Chanel S. de R.L. c. Genève Accessoires Inc. et al 2008 CF 87

13. Amender une déclaration pour ajouter un défendeur
    Microsoft Corporation c. Carmelo Cerrelli et al. 2008 CF 117

14. Reconnaissance de la contrefaçon d’un brevet par incitation
    Charles D. MacLennan et Quadco Equipment Inc. c. Les Produits Gilbert Inc., 2008 CAF 35. (décision rendue par le Juge Noël et appuyée par le Juge Nadon et le Juge Pelletier).

15. Motion to Strike Application Exceptional
    Sanofi-Aventis Canada Inc. v. Canada (Minister of Health), 2008 FC 129 (Hughes, J.)

16. Sufficiency of disclosure must be raised in NOA
    Apotex Inc. v. Eli Lilly Canada Inc. et al. 2008 FCA 44 (Noel J.A.)

17. Proper Disclosure for Sound Prediction must be in Patent
    Eli Lilly Canada Inc. v. Apotex Inc. et al. 2008 FC 142 (Hughes, J.)

18. The Registrar of Trade-marks is Required to Reverse an Expungement and Re-instate the Registration if Ordered by the Federal Court of Appeal
    Cheaptickets and Travel Inc. v. Emall.ca Inc. and Emall Inc., carrying on business as CHEAPTICKETS.CA, 2008 FC 50 (Décary J.A., Sharlow J.A., Trudel J.A.)

19. Distinguishing Guise is Crocs’ Sole Defence
    Crocs Canada Inc. and Crocs, Inc. v. Holey Soles Holdings Ltd. 2008 FC 188 (Hugessen, J.)

20. Amendments to Statements of Claim Held Unacceptable
    Harrison v. Sterling Lumber Company 2008 FC 220 (Simpson, J.)

21. Expert Fees Not So Unreasonable to Suggest Assessment Officer Error
    Biovail Corporation v. Canada (Health) 2008 FC 278 (Simpson, J.)

22. Anticipation – The Prior User Must Know What He is Doing
    Calgon Carbon Corporation v. The Corporation of the City of North Bay and Trojan Technologies Inc., 2008 FCA 81 (Linden, Sexton, Ryer, JJ.A.)

23. No Fishing Where There Is Case Management
    Eli Lilly Canada Inc. v. Novopharm Limited 2008 FC 281 (Lemieux J.)

24. Interchangeability Does Not Equal Inducement
    Sanofi-Aventis Canada Inc. v. Laboratoire Riva Inc., 2008 FC 291 (Martineau, J.)

25. Allegation of Bias Premature At Interlocutory Stage
    Sanofi Pasteur Ltd. v. Attorney General of Canada 2008 FC 286 (Martineau J.)

26. Question of Mootness Is Not ‘Plain and Obvious’
    Hässle v. Apotex 2008 FCA 88 (Sexton, J.A.)

27. Additional Case Law May Be Argued on an Appeal of a Prothonotary, But at a Price
    J2 Global Communications v. Protus IP Solutions 2008 FC 298 (Simpson, J.)

28. Notice of Compliance for Old Use of Pantoprazole
    Solvay Pharma Inc., et al. v. Apotex, et al. 2008 FC 308 (Gauthier J.)

29. Application dismissed: patent not eligible for listing
    Nycomed Canada Inc. v. Novopharm Ltd., 2008 FC 313 (Prothonotary Milczynski)

30. Appeal from Prothonotary’s Order Dismissing Motion for Particulars or to Strike Certain Paragraphs of the Defendants’ Pleadings Dismissed
    Mövenpick-Holding v. Inter Management Services Limited et al 2008 FC 328 (Lagacé J.)

31. No Fishing In Privileged Areas
    Les Laboratoires Servier et al v. Apotex Inc. et al 2008 FC 321 (Snider J.)

32. Relief from the Implied Undertaking Rule
    Sanofi-Aventis Canada v. Apotex 2008 FC 320 (Snider, J.)

33. The Commissioner Has No Discretion When Applicants Miss Deadlines
    Actelion Pharmaceuticals Ltd. v. Canada and the Commissioner of Patents, 2008 FCA 90 (Sexton, Nadon, Ryer JJ.A.)

34. Court considers listing of patent and motion to dismiss application under s. 6(5)(b)
    Nycomed GmbH v. Canada (Minister of Health), 2008 FC 330 (Prothonotary Milczynski)

35. Section 78.6 Is Not For Correction of Non-Payment of Fees
    Wicks v. Commissioner of Patents 2008 FCA 96 (Sharlow J.A.)

36. You’re Disqualified!
    Robbins Myers Canada Ltd. v. Torque Control Systems Ltd. et al 2008 FC 332 (O’Keefe J.)

37. Request by Officer for Authorization to Represent Corporate Party Denied
    Farouk Systems Inc. v. Rica International Inc. and Munesh M. Mavadia, 2008 FC 357 (Dawson J.)

38. Consideration of Related Patents Does Not Constitute Re-litigation
    Abbott Laboratories v. Minister of Health 2008 FCA 96 (Barnes J.)

39. Security for Costs Denied Pending Appeal of Judgement Awarding Costs
    9038-3746 Quebec Inc., 9014-5731 Quebec Inc., Adam Cerrelli and Carmelo Cerrelli v. Microsoft Corporation, 2008 FCA 104 (Richard C.J.)
40. A Modified Notice of Appearance Cannot be Served and Filed
    Schering-Plough Canada Inc. v. Pharmascience Inc. 2008 FC 359 (Beaudry, J.)
41. Section 27(3) of the Patent Act Requires Sufficiency of Disclosure, Not Sufficiency of Data Underlying the Disclosure
    Pfizer Canada Inc. v. Minister of Health 2008 FCA 108 (Nadon J.)
42. Evidence related to disbursements cannot be dismissed out-of-hand
    Fournier Pharma Inc. v. Canada (Minister of Health), 2008 FC 369 (Heneghan J.)
43. Accuracy and Detail Imperative in a Claim to Costs on Summary Judgment
    Crocs Canada Inc. and Crocs, Inc. v. Holey Soles Holdings Ltd. 2008 FC 384 (Hugessen, J.)